Document is current
Any future updates will be listed below
-
Authors
Martínez-Ginés, M.L.
García-Domínguez, J.M.
Cuello, J.P.
Meca-Lallana, V.
Aguirre, C.
Costa-Frossard, L.
Monreal, E.
Sainz de la Maza, S.
Salgado-Cámara, P.
Labiano-Fontcuberta, A.
Fernández-Cabredo, L.
Aladro-Benito, Y.
Canelo, L.B.
Valle, O.Sánchez-del
Blasco, M.R.
Sabin-Muñoz, J.
Caminero-Rodríguez, A.B.
Gracia-Gil, J.
Fernandez-Diaz, E.
Mendoza-Rodríguez, A.
Gómez-Moreno, M.
Orviz-García, A.
Moreno-Torres, I.
Casanova-Peño, L.I.
Lozano-Ros, A.
-
Funding
Funding for this research was provided by:
Sanofi Aventis SA
Sanofi
- License Information
-
More Information
This article is maintained by: Elsevier
Article Title: Real-life safety and effectiveness outcomes of teriflunomide in patients with relapsing–remitting multiple sclerosis: The TERICAM study
Journal Title: Neurology Perspectives
CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.neurop.2023.100133
Content Type: article
Copyright: © 2023 Sociedad Española de Neurología. Published by Elsevier España, S.L.U.
